127 related articles for article (PubMed ID: 35887930)
1. Comprehensibility of Contraindications in German, UK and US Summaries of Product Characteristics/Prescribing Information-A Comparative Qualitative and Quantitative Analysis.
Then MI; Andrikyan W; Fromm MF; Maas R
J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887930
[TBL] [Abstract][Full Text] [Related]
2. Inconsistencies and Ambiguities in Liver-Disease-Related Contraindications-A Systematic Analysis of SmPCs/PI of Major Drug Markets.
Weisbach L; Schuster AK; Hartmann M; Fromm MF; Maas R; Farker K
J Clin Med; 2022 Mar; 11(7):. PubMed ID: 35407541
[TBL] [Abstract][Full Text] [Related]
3. The CredibleMeds
Then MI; Andrikyan W; Maas R; Fromm MF
Br J Clin Pharmacol; 2022 Jan; 88(1):226-236. PubMed ID: 34156728
[TBL] [Abstract][Full Text] [Related]
4. [Different number of contraindications between summaries of product characteristics (SmPC) of drugs with the same active ingredients - an analysis of data from SmPCs of neuropsychiatric drugs].
Gahr M; Freudenmann RW; Connemann BJ; Schönfeldt-Lecuona C; Muche R; Hiemke C; Sillmann YM
Fortschr Neurol Psychiatr; 2020 Mar; 88(3):152-169. PubMed ID: 31127605
[TBL] [Abstract][Full Text] [Related]
5. Inconsistencies of absolute drug-drug contraindication reports: Analysis of Summaries of Product Characteristics of commonly prescribed drugs.
Weisbach L; Schuster AK; Hartmann M; Dürr P; Then MI; Andrikyan W; Fromm MF; Maas R; Farker K
Br J Clin Pharmacol; 2023 Aug; 89(8):2552-2560. PubMed ID: 37002812
[TBL] [Abstract][Full Text] [Related]
6. Harmonization of summaries of product characteristics (SmPCs) of drugs with the same active ingredients: an evaluation of SmPCs of the most frequently prescribed active substances.
Gahr M; Connemann BJ; Muche R; Zeiss R; Wolf A
Eur J Clin Pharmacol; 2022 Mar; 78(3):419-434. PubMed ID: 34705065
[TBL] [Abstract][Full Text] [Related]
7. Inconsistencies and misleading information in officially approved prescribing information from three major drug markets.
Pfistermeister B; Saß A; Criegee-Rieck M; Bürkle T; Fromm MF; Maas R
Clin Pharmacol Ther; 2014 Nov; 96(5):616-24. PubMed ID: 25062063
[TBL] [Abstract][Full Text] [Related]
8. Information for adequate prescribing to older patients : an evaluation of the product information of 53 recently approved medicines.
Beers E; Egberts TC; Leufkens HG; Jansen PA
Drugs Aging; 2013 Apr; 30(4):255-62. PubMed ID: 23420118
[TBL] [Abstract][Full Text] [Related]
9. Risk of Cleft Lip and/or Palate Associated With Antiepileptic Drugs: Postmarketing Safety Signal Detection and Evaluation of Information Presented to Prescribers and Patients.
Rezaallah B; Lewis DJ; Zeilhofer HF; Berg BI
Ther Innov Regul Sci; 2019 Jan; 53(1):110-119. PubMed ID: 29714593
[TBL] [Abstract][Full Text] [Related]
10. [Use of summaries of product characteristics (SmPC) among family doctors and pharmacists in the context of the aut-idem regulation: Results of an exploratory cross-sectional survey].
Gahr M; Freudenmann RW; Connemann BJ; Schönfeldt-Lecuona C; Muche R; Hiemke C; Sillmann YM
Z Evid Fortbild Qual Gesundhwes; 2020 Apr; 150-152():45-53. PubMed ID: 32444219
[TBL] [Abstract][Full Text] [Related]
11. A systematic review of the safety information contained within the Summaries of Product Characteristics of medications licensed in the United Kingdom for Attention Deficit Hyperactivity Disorder. how does the safety prescribing advice compare with national guidance?
Savill N; Bushe CJ
Child Adolesc Psychiatry Ment Health; 2012 Jan; 6(1):2. PubMed ID: 22234242
[TBL] [Abstract][Full Text] [Related]
12. What should patients do if they miss a dose? A systematic review of patient information leaflets and summaries of product characteristics.
Albassam A; Hughes DA
Eur J Clin Pharmacol; 2021 Feb; 77(2):251-260. PubMed ID: 32989529
[TBL] [Abstract][Full Text] [Related]
13. Shaping medicinal product information: a before and after study exploring physicians' perspectives on the summary of product characteristics.
Vromans L; Doyle G; Petak-Opel S; Rödiger A; Röttgermann M; Schlüssel E; Stetter E
BMJ Open; 2013 Aug; 3(8):e003033. PubMed ID: 23965932
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Information in Summaries of Product Characteristics (SmPCs) on the Use of a Medicine in Patients With Hepatic Impairment.
Weersink RA; Timmermans L; Monster-Simons MH; Mol PGM; Metselaar HJ; Borgsteede SD; Taxis K
Front Pharmacol; 2019; 10():1031. PubMed ID: 31607904
[No Abstract] [Full Text] [Related]
15. Clinical relevance of information in the Summaries of Product Characteristics for dose adjustment in renal impairment.
Salgado TM; Arguello B; Martinez-Martinez F; Benrimoj SI; Fernandez-Llimos F
Eur J Clin Pharmacol; 2013 Nov; 69(11):1973-9. PubMed ID: 23884582
[TBL] [Abstract][Full Text] [Related]
16. Information in summaries of product characteristics about use in children is limited and needs standardisation: a systematic analysis in Switzerland.
Tilen R; Berger C; Allemann S; Meyer Zu Schwabedissen H
Arch Dis Child; 2024 Jun; 109(7):586-591. PubMed ID: 38448199
[TBL] [Abstract][Full Text] [Related]
17. Comparison of pregnancy and lactation labeling for attention-deficit hyperactivity disorder drugs marketed in Australia, the USA, Denmark, and the UK.
Warrer P; Aagaard L; Hansen EH
Drug Saf; 2014 Oct; 37(10):805-13. PubMed ID: 25112669
[TBL] [Abstract][Full Text] [Related]
18. Natural language processing-based assessment of consistency in summaries of product characteristics of generic antimicrobials.
Shimazawa R; Kano Y; Ikeda M
Pharmacol Res Perspect; 2018 Dec; 6(6):e00435. PubMed ID: 30455958
[TBL] [Abstract][Full Text] [Related]
19. [Sleep disorders and impaired sleep as adverse drug reactions of psychotropic drugs: an evaluation of data of summaries of product characteristics].
Gahr M; Connemann BJ; Zeiss R; Fröhlich A
Fortschr Neurol Psychiatr; 2018 Jul; 86(7):410-421. PubMed ID: 29499579
[TBL] [Abstract][Full Text] [Related]
20. The Quality and Reliability of Information in the Summaries of Product Characteristics.
Drelich E; Religioni U; Chung K; Kaźmierczak J; Blicharska E; Neumann-Podczaska A; Krysiński J; Merks P
Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
